Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I wonder if there might be considerable blowback if topline data were extremely good and at the same time the company had to confess they didn't have the technology to administer their vaccine to all but a few patients.
I disagree. In quantum physics the observer determines the nature of the particle which, until that moment, is indeterminate. Since no observer has been able to view the state of nwbo in the quiet period we don't know whether the cat is dead or alive.
I note the main difference in those two reports is that one specifies trained. That could explain the discrepancy. The other possibility is that one appears to be a press report and the other a company statement. Then it's a question of where did the reporter get their info.
It could be a way to add a new element of FUD if you think about it.
Everywhere. Google Ukraine
Russia has invaded Ukraine
I believe two of Zeno's paradoxes are in play here. If you sell off half your stock every quarter you will never dispose of all your stock, the Achilles and the Tortoise paradox. The second one involves nwbo and the dichotomy paradox. They will never reach their goal as they must reach halfway and before that halfway to the halfway mark etc. Two paradoxes on 22022022.
Interesting that the chart indicates only a few days with volume in excess of 5 million shares traded and only one day with 10 million shares traded. That's the volume I would expect if we were to see a strong move back well above a dollar.
Fleshworks.
Oh, wait. That's a website---
Never mind
Quickly if they do a reverse split on top of excellent news. Longer if they allow the market to sort it out.
I see Adam's skirmishers are already out. I suppose the main assault will commence right around opening bell.
As currently written, an eua couldn't be approved for cancer vaccines.
I posted that specifically to show how many areas of immunotherapy they're working on. I wouldn't get your hopes up. Nice if it is about DC-Vax but it's just one of many.
The OSUCCC – James world-renowned cancer experts use many different types of immunotherapy to treat cancer. These can include:
CAR-T Cell Therapy, which genetically improves a patient’s white blood cells and then uses them to kill cancer cells.
Cytokine Therapy, which uses the body’s naturally occurring hormone-like protein molecules to bolster immune responses.
Monoclonal Antibodies, which are drugs designed to attach to specific cell-targets in the body and create an immune response that destroys cancer cells.
Adoptive Cell Transfer, which bolsters the ability of T cells to combat cancer by removing them from a patient’s tumor, then isolating or altering the cells that are most active against cancer. CAR-T cell therapy is an example of adoptive cell transfer treatment.
Vaccines, which are designed to stimulate the body’s immune system to produce antibodies against specific antigens on a cancer cell.
Drug Therapy, which uses drugs developed to block mechanisms that enable cancer cells to hide from the immune system. Nivolumab, for example, blocks a certain receptor on T cells, freeing them to attack cancer cells.
https://cancer.osu.edu/for-patients-and-caregivers/learn-about-cancers-and-treatments/innovation-at-the-james/immunotherapy
The link takes you to the Epoch Times so not really a major news source.
Volume isn't. In fact it's pretty dismal.
When it comes to small bios you have to ask yourself before buying is it real or is it just meme rx
This week's price action is a repeat of week before last. Day traders are making money here and as far as it reflecting anticipation of data, it doesn't. The beatings will continue until morale improves.
Is that you George?
All plan B restrictions, including face masks, removed in England.
https://www.theguardian.com/world/2022/jan/19/boris-johnson-announces-end-to-all-omicron-covid-restrictions-in-england
I said that.
Ah, I read post 436154 and today's date at the top. Didn't see it was from last year. Speculative comments I made remain relevant though.
The Larry Smith update posted earlier today returned to the game stop scenario a few times and had repeated reference to naked shorts. He's speculating nwbo could become another game stop I think but there's two things wrong with that. The number of shares outstanding here and the fact that we aren't listed on an exchange the reddit group, for the most part, can trade on. Even if they could trade nwbo there are too many shares to effect a huge increase in share price. His repeated return to that theme leads me to question everything else he said.
A rally in anticipation of news would exceed the daily average by several times. There are nearly a billion shares of nwbo outstanding. Even a 20 million share day would represent only a fraction of the total.
When I see this sort of increase or decrease I always check the volume. If it's not significantly better than average I ignore it. Day traders love days like today.
Volume says this is a headfake. I don't expect it to hold.
A rehash of news from last year repackaged to keep nrxp afloat.
Rising on limited volume just like week before last. It's meaningless.
I agree 100%. The recent financing round was in November. Look at the chart since then. There has been a steady price decline. Then read this.
The Company plans to use the funding to help accelerate its activities related to its brain cancer program. The financing is in the form of a 22-month loan which requires no payments for 8 months, and then provides for a subsequent 14-month amortization period. The loan has a provision for prepayment, an annualized interest rate of 8% and OID of 10%. Upon announcement of the top line data (“TLD”) from the Company’s Phase III clinical trial of DCVax®-L for Glioblastoma brain cancer, the lender will have a then-springing right to exchange the outstanding balance of the loan for common shares priced at the price of the first private placement transaction following TLD less a 12% discount, and to purchase another 50% of that number of shares at the same price. This then-springing right expires 14 days after that post-TLD private placement.
Those x-rays were debunked by a lab technician who pointed out they were taken from a different angle than claimed in the report.
No volume
Never mind. I see JJ counter sued.
Tanking on the Swiss exchange this morning. Any news?
That article is a year old and the 2022 JP Morgan Healthcare conference starts today. Maybe he will update his comments
Simply insert vaccine into your post in place of the named virus and it's equally true.
The ultimate takedown of amrn occurred after they lost their patents. As I recall, up until that point they had lost roughly 50% from their high. I also recall that AF was instrumental in orchestrating the price decline before the loss of their patents. If any company serves better as a cautionary tale regarding the ability of shorts to harm a stock using an orchestrated attack I'm not aware of it.
Bear raid? Volume suggests it's not because of news.
Interesting article. A nurse on the verge of death was revived because she was given a large dose of viagra. Since aviptadil is also an erectile dysfunction drug perhaps all ed drugs work to clear the lungs. Hmm
https://www.dailymail.co.uk/news/article-10362771/Nurse-wakes-28-day-Covid-coma-medics-VIAGRA.html
I think this is another attempt by JJ to keep nrxp above 5 dollars. The timing is fortuitous don't you think? It also has the distinctive smell of data mining.
Has the fda accepted the endpoint change?